Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, and tolerability of
extended-release niacin (Niaspan) in improving the level of fats in the blood of HIV-infected
patients.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)